- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03337555
A Comparison of McGrath MAC®, Pentax-AWS® and Macintosh Direct Laryngoscopes for Nasotracheal Intubation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This trial is prospective randomized trial. The Objects are adult patients who need nasotracheal intubation for surgery. Using computed randomized table, participants are assigned to three groups, McGrath MAC®, Pentax-AWS® and Macintosh direct laryngoscopes.
The intubation will be done by One expert anesthesiologist who have more than 10 years experience.
Investigators compare intubation time, success rate and difficulty between three groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gyeonggi-do
-
Suwon, Gyeonggi-do, Korea, Republic of, 16499
- Ajou university schoole of medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 19 years old
- ASA I or II
- Patients who need nasotracheal intubation for surgery
Exclusion Criteria:
- Anatomical deformity in head and neck
- Modified Mallampati score IV
- Bleeding tendency in preoperative evaluation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Macintosh
intubation using Macintosh direct laryngoscope
|
Macintosh direct laryngoscope
|
|
Experimental: McGrath
intubation using McGrath MAC®
|
McGrath videolaryngoscope
|
|
Experimental: Pentax
intubation using Pentax-airway scope®
|
Pentax videolaryngoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intubation time
Time Frame: within 5 minutes
|
from endotracheal tube pass the nostril to end-tidal CO2 appear
|
within 5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate
Time Frame: within 5 minutes
|
Failure defined intubation time more than 120sec or SaO2 less than 95%
|
within 5 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yun Jeong Chae, MD, Ajou University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AJIRB-MED-OBS-17-327
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.